Cargando…
Characterization of the Early CNS Stress Biomarkers and Profiles Associated with Neuropsychiatric Diseases
Neuropsychiatric disorders (including dementia) have high personal, family, and social costs. Although many neuropsychiatric disorders share common patterns of symptoms and treatments, there are no validated biomarkers that define the underlying molecular mechanisms in the central nervous system (CN...
Autores principales: | Lowe, XR, Wyrobek, AJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426783/ https://www.ncbi.nlm.nih.gov/pubmed/23449133 http://dx.doi.org/10.2174/138920212802510448 |
Ejemplares similares
-
MicroRNAs as biomarkers for CNS disease
por: Rao, Pooja, et al.
Publicado: (2013) -
The Role of Oxytocin in Early-Life-Stress-Related Neuropsychiatric Disorders
por: Jin, Yue, et al.
Publicado: (2023) -
Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021) -
Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
por: Bhattacharya, Anindya
Publicado: (2018) -
Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia
por: Bandyopadhyay, Tushar Kanti, et al.
Publicado: (2014)